- Home
- HCM vs OMCL Comparison
HCM vs OMCL Comparison
Compare HCM & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCM | OMCL |
|---|---|---|
| Founded | 2000 | 1992 |
| Country | Hong Kong | United States |
| Employees | 1796 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | HCM | OMCL |
|---|---|---|
| Price | $10.96 | $37.83 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $13.75 | ★ $55.83 |
| AVG Volume (30 Days) | 57.4K | ★ 476.6K |
| Earning Date | 03-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | $20.60 | $6.77 |
| Revenue Next Year | $15.62 | $5.22 |
| P/E Ratio | ★ $5.49 | $151.28 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $10.40 | $26.85 |
| 52 Week High | $19.50 | $51.84 |
Technical Indicators
Market Signals| Indicator | HCM | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 32.71 | 35.32 |
| Support Level | N/A | $35.44 |
| Resistance Level | $15.59 | $45.06 |
| Average True Range (ATR) | 0.33 | 1.75 |
| MACD | 0.02 | -0.83 |
| Stochastic Oscillator | 35.26 | 17.63 |
Price Performance
Historical ComparisonAbout HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.